Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,97 USD | +0,25 % | -0,25 % | -24,67 % |
13/03 | BIOVENTUS INC. : recomendación de compra de Craig-Hallum | ZM |
12/03 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
Resumen de negocios
Número de empleados: 970
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pain Treatments
43,1
%
| 216 | 42,2 % | 221 | 43,1 % | +2,07 % |
Surgical Solutions
30,1
%
| 141 | 27,6 % | 154 | 30,1 % | +9,43 % |
Restorative Therapies
26,8
%
| 155 | 30,2 % | 137 | 26,8 % | -11,36 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
87,8
%
| 455 | 88,9 % | 450 | 87,8 % | -1,18 % |
International
12,2
%
| 57 | 11,1 % | 62 | 12,2 % | +9,88 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Claypoole
CEO | Chief Executive Officer | - | 10/01 |
Mark Singleton
DFI | Director of Finance/CFO | 55 | 21/03/22 |
Katrina Church
CMP | Compliance Officer | 62 | - |
Dave Crawford
IRC | Investor Relations Contact | - | 23/08/21 |
Helen Leupold
HRO | Human Resources Officer | - | 01/06/22 |
Anthony Doyle
PRN | Corporate Officer/Principal | - | 01/04/17 |
Andrew Hosmer
PRN | Corporate Officer/Principal | - | 01/05/12 |
Anthony D'Adamio
LAW | General Counsel | 63 | 01/08/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
William Hawkins
CHM | Chairman | 70 | 30/06/16 |
Guy Nohra
BRD | Director/Board Member | 63 | 01/01/20 |
Martin Sutter
BRD | Director/Board Member | 68 | 30/06/16 |
Susan Stalnecker
BRD | Director/Board Member | 71 | 01/09/20 |
Guido Neels
BRD | Director/Board Member | 75 | 01/01/20 |
Director/Board Member | 53 | 08/01/23 | |
Mary Ladone
BRD | Director/Board Member | 57 | 15/07/21 |
Philip G. Cowdy
BRD | Director/Board Member | 56 | 30/06/16 |
Patrick Beyer
BRD | Director/Board Member | 58 | 29/10/21 |
Director/Board Member | 54 | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 15 786 737 | 0 | 0 | 67,20 % |
Acción B | 1 | 63 827 617 | 53 500 383 ( 83,82 %) | 0 |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-24,67 % | 253 M | |
+73,37 % | 12,39 mil M | |
-17,09 % | 8082,94 M | |
+16,88 % | 7249,1 M | |
+3,57 % | 5857,57 M | |
+11,77 % | 5351,31 M | |
+29,65 % | 4631,71 M | |
-17,74 % | 4191,58 M | |
-35,26 % | 2443,55 M | |
+3,09 % | 2070,28 M |
- Bolsa de valores
- Acciones
- Acción BVS
- Empresa Bioventus Inc.